The benchtop sequencing platform provides laboratories with accurate long-read sequencing
Biotechnology company PacBio has recently introduced the Vega system, a sequencing platform designed to provide laboratories with accurate long-read sequencing.
“Vega is the realisation of our vision to expand access to our advanced sequencing technology,” said Christian Henry, President and Chief Executive Officer of PacBio.
“Starting with the launch of Revio in early 2023, we’ve been steadily executing on our strategy, building a portfolio of products that address the full spectrum of research demands.”
The benchtop sequencing platform offers HiFi technology and a fast turnaround time for a variety of applications, including targeted sequencing, RNA sequencing and small genome sequencing.
The system’s HiFi technology is compatible with the existing HiFi ecosystem for library preparation and data analysis.
With one SMRT cell per run, Vega has a throughput of 600 full-length RNA samples per year using the Kinnex full-length RNA kit, 9,600 samples using the PureTarget repeat expansion panel, or 200 human genomes.
SMRT Link Cloud software enables operators to manage instruments without on-premises compute.
PacBio displayed its Vega system at the American Society of Human Genetics annual meeting in Denver earlier this year.
